Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does PIMAVANSERIN Cause Therapeutic product effect variable? 25 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 25 reports of Therapeutic product effect variable have been filed in association with PIMAVANSERIN (pimavanserin). This represents 0.1% of all adverse event reports for PIMAVANSERIN.

25
Reports of Therapeutic product effect variable with PIMAVANSERIN
0.1%
of all PIMAVANSERIN reports
1
Deaths
1
Hospitalizations

How Dangerous Is Therapeutic product effect variable From PIMAVANSERIN?

Of the 25 reports, 1 (4.0%) resulted in death, 1 (4.0%) required hospitalization.

Is Therapeutic product effect variable Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for PIMAVANSERIN. However, 25 reports have been filed with the FAERS database.

What Other Side Effects Does PIMAVANSERIN Cause?

Hallucination (10,839) Death (9,352) Drug ineffective (5,545) Product dose omission issue (3,808) Confusional state (3,779) Fall (3,366) Delusion (2,421) Hallucination, visual (1,954) Gait disturbance (1,923) Parkinson's disease (1,918)

What Other Drugs Cause Therapeutic product effect variable?

CARBIDOPA\LEVODOPA (316) LEVODOPA (298) RIMEGEPANT (177) GABAPENTIN (166) CLOZAPINE (157) DICLOFENAC (153) OLANZAPINE (150) FLUOXETINE (149) ARIPIPRAZOLE (148) AMISULPRIDE (147)

Which PIMAVANSERIN Alternatives Have Lower Therapeutic product effect variable Risk?

PIMAVANSERIN vs PIMECROLIMUS PIMAVANSERIN vs PIMOZIDE PIMAVANSERIN vs PINAVERIUM PIMAVANSERIN vs PINDOLOL PIMAVANSERIN vs PIOGLITAZONE

Related Pages

PIMAVANSERIN Full Profile All Therapeutic product effect variable Reports All Drugs Causing Therapeutic product effect variable PIMAVANSERIN Demographics